immovable < immune < immunisatie

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 97.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000036 (2002)	N. Hehme [Allemagne] ; H. Engelmann [Allemagne] ; W. Künzel [Allemagne] ; E. Neumeier [Allemagne] ; R. S Nger [Allemagne]	Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines
000069 (2012)	H. D. Klenk [Allemagne]	Evolution und Infektionsbiologie neuer Influenza-A-Viren mit pandemischem Potenzial
000086 (1999)	Hunein F. Maassab [États-Unis] ; Martin L. Bryant [États-Unis]	The development of live attenuated cold‐adapted influenza virus vaccine for humans
000092 (2000)	N. V. Kaverin ; Y. A. Smirnov ; E. A. Govorkova ; I. A. Rudneva ; A. K. Gitelman ; A. S. Lipatov ; N. L. Varich ; S. S. Yamnikova ; N. V. Makarova ; R. G. Webster [États-Unis] ; D. K. Lvov	Cross-protection and reassortment studies with avian H2 influenza viruses
000118 (1979)	G. C. Schild	The influenza virus: Antigenic composition and immune response.
000158 (1984)	E. Schiltknecht [Australie] ; G. L. Ada [Australie] ; T. J. Braciale [États-Unis]	Macrophage procoagulant-inducing activity of influenza-specific effector T cells
000180 (1986)	M. E. Andrew [Australie] ; B. E. H. Coupar [Australie] ; G. L. Ada [Australie] ; D. B. Boyle [Australie]	Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants
000188 (1992)	Susan B. Dillon [États-Unis] ; Sandra G. Demuth [États-Unis] ; Mark A. Schneider [États-Unis] ; Cynthia B. Weston [États-Unis] ; Christopher S. Jones [États-Unis] ; James F. Young [États-Unis] ; Miller Scott [États-Unis] ; Pradip K. Bhatnaghar [États-Unis] ; Stephen Locastro [États-Unis] ; Nabil Hanna [États-Unis]	Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant
000265 (1995)	M. Aymard [France] ; M. F. Odelin [France] ; J. Million-Jolly [France]	Immunité antigrippale
000289 (2000)	Eric C. J Claas [Pays-Bas]	Pandemic influenza is a zoonosis, as it requires introduction of avian-like gene segments in the human population
000367 (2011)	Thomas Han [États-Unis] ; Wayne A. Marasco [États-Unis]	Structural basis of influenza virus neutralization
000406 (1990)	Koichi Kuwano [États-Unis] ; Manabu Tamura [États-Unis] ; Francis A. Ennis [États-Unis]	Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone
000431 (1979)	C. Scholtissek [Allemagne]	The genes coding for the surface glycoproteins of influenza A viruses contain a small conserved and a large variable region
000466 (2012)	R. Allwinn [Allemagne] ; M. Bickel [Allemagne] ; C. Lassmann [Allemagne] ; S. Wicker [Allemagne] ; I. Friedrichs [Allemagne]	“Trivalent influenza vaccination of healthy adults 3 years after the onset of swine-origin H1N1 pandemic: restricted immunogenicity of the new A/H1N1v constituent?”
000520 (1978)	Ch. Kunz [Autriche] ; H. Hofmann [Autriche] ; A. Moritz [Autriche] ; H. Bachmayer [Autriche] ; E. Liehl [Autriche]	Eine neue Influenza Subunit Vakzine: Hämagglutinations-hemmende Antikörper ein Jahr nach der Impfung
000525 (1997)	Julia R. Romanova [Russie] ; Gregory A. Tannock [Australie] ; Galina I. Alexandrova [Russie]	Protective responses in mice to vaccination with multiply administered cold-adapted influenza vaccine reassortants and wild-type viruses
000551 (1994)	K. Scheepers [Allemagne] ; H. Becht [Allemagne]	Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes
000569 (2008)	Julian W. Tang [République populaire de Chine] ; Karry L. K. Ngai [République populaire de Chine] ; Paul K. S. Chan [République populaire de Chine, Hong Kong]	Lack of cross‐immune reactivity against influenza H5N1 from seasonal influenza vaccine in humans
000584 (2000)	K. Subbarao [États-Unis] ; J. Katz [États-Unis]	Avian influenza viruses infecting humans
000603 (2011)	A. Fierro [Italie] ; A. Liccardo [Italie]	A simple stochastic lattice gas model for H1N1 pandemic. Application to the Italian epidemiological data
000618 (2007)	William B. Ershler [États-Unis] ; Stefan Gravenstein [États-Unis] ; Zeba S. Geloo [États-Unis]	Thymosin Alpha 1 as an Adjunct to Influenza Vaccination in the Elderly

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "immune" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "immune" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    immune
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021